Novofem (Estradiol | Norethisterone Acetate, Estradiol)

The formulation contains estradiol, an estrogen, and norethisterone acetate, a progestogen. Estradiol stabilizes the uterine lining, while the progestogen suppresses the hypothalamic‑pituitary‑ovarian axis, preventing the luteinizing hormone surge that triggers ovulation. It also thickens cervical mucus and alters the endometrium, making conception unlikely.

The dosing regimen for Novofem is determined by the prescribing healthcare professional. Typically, the product is taken once daily as a single tablet, but the exact schedule, duration, and any missed‑dose instructions are set by the prescriber based on individual patient needs.

Novofem is contraindicated during pregnancy and should not be started or continued if a woman becomes pregnant. While limited data exist for breastfeeding, most guidelines advise caution; the benefits and risks should be evaluated by a healthcare provider before use in nursing mothers.

To order Novofem, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. The sales team will verify trade or institutional credentials and then respond with pricing, availability, shipping details and any required import documentation.

Novofem contains the same hormone classes—estrogen and progestogen—as other combined oral contraceptives, but its specific ratio of estradiol to norethisterone acetate may offer a different side‑effect profile or cycle‑control characteristics. Clinical effectiveness in preventing pregnancy is comparable, while individual tolerability can vary between products.

Novofem tablets should be stored at room temperature, below 25 °C. Keep them in the original blister pack or container, protect from moisture, direct sunlight and excessive heat. Do not store in bathrooms or near kitchen appliances that generate steam.

Novofem is taken orally, usually once each day at the same time, with or without food. Patients should follow the prescriber’s instructions regarding the start of the first pack, any placebo days, and actions to take if a dose is missed.

Serious but rare risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. Severe allergic reactions (anaphylaxis) and significant liver dysfunction have also been reported. Patients should seek immediate medical attention if they experience symptoms like sudden leg pain, shortness of breath, chest pain, or severe rash.

Novofem should not be used by women who are pregnant, have a known hypersensitivity to any component, smoke and are over 35 years of age, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, or certain hormone‑dependent cancers. A thorough medical review is required before initiation.